A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

CC-11050

Trial Locations (1)

ICON Early Phase Services, San Antonio